Header Logo

Connection

ERIC ROHREN to Clinical Trials, Phase I as Topic

Back to Details
This is a "connection" page, showing publications ERIC ROHREN has written about Clinical Trials, Phase I as Topic.
ERIC ROHREN
Connection Strength
0.122
Clinical Trials, Phase I as Topic
  1. Alpha Emitter Radium 223 in High-Risk Osteosarcoma: First Clinical Evidence of Response and Blood-Brain Barrier Penetration. JAMA Oncol. 2015 May; 1(2):253-5.
    View in: PubMed
    Score: 0.122
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.